Some computers are easy to spot. Artificial, human-built computers like those found in smartphones and laptops are abstract dynamic systems with observable computational elements like input, output, ...
Now, Sophia Space has raised $10 million from investors including Alpha Funds, KDDI Green Partners Fund, and Unlock Venture ...
Artificial intelligence developers are accusing Chinese firms of stealing their intellectual property following a spate of ‘distillation attacks’, despite their own alleged theft of training data.
The cerebral cortex, the brain's outermost region responsible for higher cognitive functions, depends on a highly ordered, layered structure. Its proper development requires newly generated neurons to ...
PsyPost on MSN
AI and mental health: New research links use of ChatGPT to worsened psychiatric symptoms
Generative artificial intelligence chatbots may be worsening the symptoms of some people who experience severe mental health conditions. A recent analysis of thousands of patient health records ...
Imagine trying to design a key for a lock that is constantly changing its shape. That is the exact challenge we face in ...
Residency is designed to produce highly skilled physicians that can execute under pressure. But as expectations for safety, quality and documentation have shifted, many health systems are reexamining ...
The board was originally conceived to oversee the rebuilding of Gaza, but its charter does not mention the Palestinian enclave, suggesting a possibly broader mandate. By Isabel Kershner Reporting from ...
Structure’s aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech’s stock up nearly 103% as markets closed on Monday. Structure Therapeutics’ investigational oral GLP-1 ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results